Jing Jing

573 total citations
24 papers, 203 citations indexed

About

Jing Jing is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jing Jing has authored 24 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jing Jing's work include CAR-T cell therapy research (4 papers), Esophageal Cancer Research and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jing Jing is often cited by papers focused on CAR-T cell therapy research (4 papers), Esophageal Cancer Research and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jing Jing collaborates with scholars based in China, United States and Australia. Jing Jing's co-authors include Xin Qi, Wenbiao Hu, Wenqiang Wei, Guihua Zhuang, Bert L. Lum, Leslie J. Dickmann, Eric L. Reyner, Joseph A. Ware, Matts Kågedal and Zhongfa Lu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecules.

In The Last Decade

Jing Jing

22 papers receiving 197 citations

Peers

Countries citing papers authored by Jing Jing

Since Specialization

Citations

This map shows the geographic impact of Jing Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Jing more than expected).

Fields of papers citing papers by Jing Jing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Jing. The network helps show where Jing Jing may publish in the future.

Co-authorship network of co-authors of Jing Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Jing. A scholar is included among the top collaborators of Jing Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Jing. Jing Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic Targeting of Oxidative Phosphorylation Enhances Chemosensitivity in Triple-Negative Breast Cancer via a Synergistic Nanomedicine 2025 ·Theranostics ·Xiaoding Shen, (unknown), Yihan Wang, Maodi Xie, Yunkun Li, Dayi Pan, Jing Jing, Qiyong Gong, Kui Luo	5
2	Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment 2025 ·Molecular Cancer ·(unknown), Xinmin Wang, Zihan Xu, Yanyang Liu, Jing Jing	4
3	Synthesis and luminescent properties of five-six-membered bis(metallacyclic) platinum(II) complexes bearing polypyridine alkynes 2024 ·Journal of Molecular Structure ·(unknown), Jing Jing, (unknown), (unknown), (unknown), (unknown), (unknown), Xiao-Peng Zhang	1
4	The spatiotemporal associations between esophageal and gastric cancers provide evidence for its joint endoscopic screening in China: a population-based study 2024 ·BMC Medicine ·(unknown), Xin Qi, Ruhai Bai, Mei Yang, Jing Jing, (unknown), Jizhao Wang, (unknown), Guihua Zhuang	2
5	Synthesis and Biological Activities of Luminescent 5,6-Membered Bis(Metallacyclic) Platinum(II) Complexes 2023 ·Molecules ·Jing Jing, Miao Yu, Lei Pan, (unknown), (unknown), (unknown), (unknown), Xiao-Peng Zhang	2
6	Strengthening the Key Features of Volumizing Fillers: Projection Capacity and Long-Term Persistence 2023 ·Pharmaceutics ·(unknown), Jing Jing, (unknown), (unknown), (unknown), Jimmy Faivre	6
7	Spatiotemporal Patterns of Esophageal Cancer Burden Attributable to Behavioral, Metabolic, and Dietary Risk Factors From 1990 to 2019: Longitudinal Observational Study 2023 ·JMIR Public Health and Surveillance ·(unknown), Jing Jing, (unknown), (unknown), Xin Qi, (unknown)	13
8	SUNMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin vs rituximab plus gemcitabine and oxaliplatin in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. 2023 ·Journal of Clinical Oncology ·Jason R. Westin, Adam J. Olszewski, Laura Fogliatto, Won Seog Kim, Ho‐Jin Shin, Young‐Woo Jeon, Lalita Norasetthada, Astrid Pavlovsky, Eduardo Magalhães Rego, Hao Wu, (unknown), Connie Lee Batlevi, (unknown), Elicia Penuel, Jing Jing, Michael C. Wei, Lihua E. Budde	5
9	Fixed Duration Mosunetuzumab Plus Polatuzumab Vedotin Has Promising Efficacy and a Manageable Safety Profile in Patients with BTKi Relapsed/Refractory Mantle Cell Lymphoma: Initial Results from a Phase Ib/II Study 2023 ·Blood ·Michael Wang, Sarit Assouline, Manali Kamdar, Nilanjan Ghosh, Seema Naik, (unknown), Julio C. Chávez, Ting Jia, (unknown), Ling‐Yuh Huw, Jing Jing, (unknown), Iris To, Connie Lee Batlevi, Michael C. Wei, Lihua E. Budde	18
10	Metabolomic profiling for drug-induced liver injury with autoantibodies 2022 ·International Immunopharmacology ·(unknown), (unknown), (unknown), Ming Niu, Xu Zhao, Yuming Guo, (unknown), (unknown), Zhaofang Bai, (unknown), (unknown), (unknown), Jiabo Wang, Xiaohe Xiao, Jing Jing	0
11	Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study 2021 ·BMC Cancer ·Yuxin Ding, (unknown), Yuhong Chen, Jing Jing, (unknown), Xianjie Wu, Xiaoyang Zhang, Jiali Xu, (unknown), (unknown), Zhongfa Lu	17
12	The lag effect of exposure to PM2.5 on esophageal cancer in urban-rural areas across China 2021 ·Environmental Science and Pollution Research ·(unknown), (unknown), Jing Jing, Wenbiao Hu, Wenqiang Wei, Xin Qi, Guihua Zhuang	12
13	Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology 2021 ·Clinical Pharmacology & Therapeutics ·Weize Huang, Junyi Li, Michael Z. Liao, (unknown), Jiajie Yu, Jing Jing, Naoki Kotani, Lynn Kamen, Sebastián Guelman, Dale Miles	16
14	Upper Gastrointestinal Cancer in China: Spatial Epidemiologic Evidence from Screening Areas 2020 ·Cancer Prevention Research ·(unknown), Jing Jing, Rui Li, (unknown), Peng Jia, Wenbiao Hu, Xin Qi, Wenqiang Wei, Guihua Zhuang	8
15	The associations of air pollution and socioeconomic factors with esophageal cancer in China based on a spatiotemporal analysis 2020 ·Environmental Research ·(unknown), Jing Jing, (unknown), (unknown), Wenbiao Hu, Xin Qi, Wenqiang Wei, Guihua Zhuang	21
16	Spatial distribution characteristics of tumor marker CA724 reference values in China 2019 ·Cancer Medicine ·Jing Jing, (unknown), (unknown), (unknown)	15
17	Prognostic value of PD-L1 expression in resected lung adenocarcinoma and potential molecular mechanisms 2018 ·Journal of Cancer ·Jianli Ma, (unknown), Yan Wang, Yubo Yan, Shu Zhao, Hang Liu, Jing Jing, Haihong Pu, Minghui Zhang	9
18	Assessment of RANTES levels as the indicators of plaque vulnerability in rabbit models of atherosclerosis 2014 ·Pathology - Research and Practice ·(unknown), Jing Jing, Junming Li, (unknown), Ling Fang, Bo Yang	12
19	Measurement of Human Cost Of Trajfic Accidents Using CV And SG Survey Methods 2004 ·INFRASTRUCTURE PLANNING REVIEW ·Jing Jing, (unknown), (unknown)	1
20	The unitability of 1-prime lattice-ordered rings with squares positive 1994 ·Proceedings of the American Mathematical Society ·Jing Jing	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact